Zhengyan Li Selected Research

Feminization

6/2014	Ecological risk assessment of nonylphenol in coastal waters of China based on species sensitivity distribution model.
6/2013	Seasonal variation of nonylphenol concentrations and fluxes with influence of flooding in the Daliao River Estuary, China.
10/2012	An evaluation of the combined effects of phenolic endocrine disruptors on vitellogenin induction in goldfish Carassius auratus.
9/2012	An evaluation on combination effects of phenolic endocrine disruptors by estrogen receptor binding assay.
4/2011	Removal capacity and pathways of phenolic endocrine disruptors in an estuarine wetland of natural reed bed.
10/2007	Distribution characteristics of nonylphenol in Jiaozhou Bay of Qingdao and its adjacent rivers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhengyan Li Research Topics

Disease

15	Stomach Neoplasms (Stomach Cancer) 06/2022 - 05/2016
6	Flatulence 05/2019 - 11/2017
6	Feminization 06/2014 - 10/2007
4	Carcinogenesis 06/2014 - 10/2007
3	Margins of Excision 05/2018 - 05/2016
2	Adenocarcinoma 01/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 08/2019
1	Suppuration 05/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Periprosthetic Fractures 01/2021
1	Neoplasms (Cancer) 01/2021
1	Osteoporosis 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Abdominal Abscess 08/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 08/2019
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2018
1	Neck Pain (Cervicalgia) 01/2017
1	Infections 05/2016
1	Liver Failure 05/2016
1	Respiratory Insufficiency (Respiratory Failure) 05/2016
1	Hemorrhage 05/2016
1	Multiple Organ Failure (MODS) 02/2014
1	Thrombosis (Thrombus) 02/2014

Drug/Important Bio-Agent (IBA)

6	Endocrine DisruptorsIBA 06/2014 - 10/2007
3	nonylphenolIBA 06/2014 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2017
1	pseudouridine synthasesIBA 05/2021
1	PseudouridineIBA 05/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	KinesinsIBA 01/2018
1	AlbuminsIBA 11/2017
1	Estrogens (Estrogen)FDA Link 09/2012

Therapy/Procedure

17	Gastrectomy 06/2022 - 05/2016
6	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 01/2018
6	Length of Stay 05/2019 - 11/2017
2	Operative Surgical Procedures 05/2018 - 01/2018
1	Prostheses and Implants (Prosthesis) 01/2021
1	Arthroplasty 01/2021
1	Splenectomy 08/2019
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2018
1	Enhanced Recovery After Surgery 11/2017
1	Traction 01/2017
1	Perioperative Period 05/2016
1	Operative Time 05/2016
1	Therapeutics 02/2014